Scientist - In vivo Pharmacology (m/w/x)
Date de publication :
30 octobre 2024Taux d'activité :
100%- Lieu de travail :EMEA, DE, Marburg, CSL Behring
For our In vivo Pharmacology division, we are looking for a
Scientist - In vivo Pharmacology (m/f/x)
R-245681
Fulltime / fixed-term, 1 year / tariff
The Opportunity
As scientific and technical expert for in vivo studies across several therapeutic areas but mainly focused on Hematology, the incumbent is responsible for conducting and managing research activities within this field. Thereby, the incumbent plans, initiates, coordinates and reports in vivo studies conducted internally or in collaboration with external sites. Her/his activities will furthermore involve being responsible for setting up respective relevant in vivo models of disease, writing of applications and proposals seeking ethical approval for in vivo experiments, supervising technical staff (task-based), and working in matrix teams across different functional areas.
The Role
- Plan, initiate, conduct and coordinate preclinical studies (in vivo, ex vivo, in vitro) internally or in collaboration with external sites; thereby supporting characterization of product candidates.
- Facilitate and contribute to the development of new technology approaches and infrastructure within the therapeutic area hematology
- Establish new in vivo models of disease.
- Support new ethics applications for in vivo studies.
- Actively collaborate with global, cross-continental project teams, and parties within and outside of own job function.
- Present study data at internal meetings and international congresses where appropriate.
- Support preparation of study reports and scientific publications.
- Contribute to Therapeutic Area strategies with novel and competitive approaches to treat relevant disorders.
- Contribute to Therapeutic Areas by evaluating industry or academic opportunities
- Supervise and coach/train technicians (both task-based) in the above activities.
- Ensure laboratory practices and ethics submissions for in vivo studies meet required deadlines and comply with relevant guidelines, standards and regulations.
- Actively participate in the innovation process.
Experience in the following areas is an advantage:
- Minimum of three-year experience working in in vivo models of disease in academia or industry - FELASA-B (or higher) qualification is an advantage.
- Strong background in preclinical in vivo studies, as well as expertise in the area of hematology
- Broad knowledge of relevant in vivo models e.g. models of thrombosis and hemostasis, acute neurological disorders such as stroke and cerebral hemorrhage etc.
- Expertise in establishing and troubleshooting in vivo models of disease.
- Experience in writing ethics applications for in vivo studies.
- Basic understanding of statistical analyses.
- Track record of scientific achievements.
- Basic knowledge of national laws regulating the use of GMO, basic knowledge of national laws regulating in vivo experiments.
Your Skills and Experience:
- A University Degree in a relevant field of science (e.g. Bachelor of Science in biology, molecular biology, biotechnology, hematology, physiology, pharmacology or biochemistry)
- Fluent in English. Knowledge of German is of advantage
- 4-5 years of relevant post graduate experience
- Minimum of three-year experience working with relevant in vivo models of disease in academia or industry.
What we offer
- Innovative work-environment at our R&D campus
- CSL-subsidized company bike leasing
- Access to Gym facility on campus
- 2 Wellness days per year (additional paid time off)
- Family services such as psychological support, legal advisory, family care services and more for you and your direct family
For more information, please check out our global benefits below.
We are looking forward to your application. Please ensure to apply online with your CV and certifications.
Was wir bieten
Wir möchten, dass Sie sich bei CSL wohl fühlen. Das ist wichtig und Sie sind es auch. Erfahren Sie mehr darüber, was wir bei CSL bieten .
Über CSL Behring
CSL Behring ist ein weltweit führendes Unternehmen, das hochwertige Therapeutika für Menschen mit seltenen und ernsten Krankheiten entwickelt und vertreibt. Mit unseren Medikamenten für die Therapiegebiete Immunologie, Hämatologie, Herz-Kreislauf und Stoffwechsel, Atemwegserkrankungen und Transplantationsmedizin halten wir unser Versprechen, die Lebensqualität von Patienten in mehr als 100 Ländern zu verbessern. Erfahren Sie mehr über CSL Behring .
Wir möchten, dass CSL so bunt ist wie die Welt, in der wir leben
Als globales Unternehmen mit Mitarbeitenden in über 35 Ländern steht CSL für Vielfalt, Fairness und Inklusion. Erfahren Sie mehr über Vielfalt, Fairness & Inklusion bei CSL.